MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study
Authors
Keywords
-
Journal
Biomarker Research
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-07-13
DOI
10.1186/s40364-021-00289-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non–small cell lung cancer patients
- (2020) Sachin Kumar et al. CURRENT PROBLEMS IN CANCER
- Upregulated miR‑665 expression independently predicts poor prognosis of lung cancer and facilitates tumor cell proliferation, migration and invasion
- (2020) Jinbing Xia et al. Oncology Letters
- Differential expression of circulating serum miR-1249-3p, miR-3195, and miR-3692-3p in non-small cell lung cancer
- (2020) Sachin Kumar et al. Human Cell
- CD44s Induces miR-629-3p Expression in Association with Cisplatin Resistance in Head and Neck Cancer Cells
- (2020) Junichiro Chikuda et al. Cancers
- Incorporating Parp-inhibitors in Primary and Recurrent Ovarian Cancer: A Meta-analysis of 12 phase II/III randomized controlled trials
- (2020) Ilary Ruscito et al. CANCER TREATMENT REVIEWS
- Wise Management of Ovarian Cancer: On the Cutting Edge
- (2020) Stergios Boussios et al. Journal of Personalized Medicine
- Extracellular Vesicles: New Endogenous Shuttles for miRNAs in Cancer Diagnosis and Therapy?
- (2020) Stefano Martellucci et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- miRNA profile obtained by next‑generation sequencing in metastatic breast cancer patients is able to predict the response to systemic treatments
- (2019) Antonio Martinez‑Gutierrez et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer
- (2019) Xin-Ge Zhao et al. Cell Death & Disease
- Ovarian Cancer Stemness: Biological and Clinical Implications for Metastasis and Chemotherapy Resistance
- (2019) Takeshi Motohara et al. Cancers
- Comprehensive analysis of non-small-cell lung cancer microarray datasets identifies several prognostic biomarkers
- (2019) Xiuxiu Qin et al. Future Oncology
- Management of Platinum-Resistant, Relapsed Epithelial Ovarian Cancer and New Drug Perspectives
- (2019) Eric Pujade-Lauraine et al. JOURNAL OF CLINICAL ONCOLOGY
- Exosomes promote pre-metastatic niche formation in ovarian cancer
- (2019) Wenlong Feng et al. Molecular Cancer
- Bayesian multilevel model of micro RNA levels in ovarian-cancer and healthy subjects
- (2019) Paweł Wiczling et al. PLoS One
- MiR-629-3p-induced downregulation of SFTPC promotes cell proliferation and predicts poor survival in lung adenocarcinoma
- (2019) Bin Li et al. Artificial Cells Nanomedicine and Biotechnology
- A randomized, double-blind, placebo-controlled phase 1b/2 study of ralimetinib, a p38 MAPK inhibitor, plus gemcitabine and carboplatin versus gemcitabine and carboplatin for women with recurrent platinum-sensitive ovarian cancer
- (2019) Ignace Vergote et al. GYNECOLOGIC ONCOLOGY
- Wnt Signaling in Ovarian Cancer Stemness, EMT, and Therapy Resistance
- (2019) Teeuwssen et al. Journal of Clinical Medicine
- Regulation of Oncogenic Targets by miR-99a-3p (Passenger Strand of miR-99a-Duplex) in Head and Neck Squamous Cell Carcinoma
- (2019) Reona Okada et al. Cells
- miR‑149‑5p promotes chemotherapeutic resistance in ovarian cancer via the inactivation of the Hippo signaling pathway
- (2018) Manman Xu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- miR-99a-5p acts as tumor suppressor via targeting to mTOR and enhances RAD001-induced apoptosis in human urinary bladder urothelial carcinoma cells
- (2018) Te-Fu Tsai et al. OncoTargets and Therapy
- miR‑148a‑3p suppresses epithelial ovarian cancer progression primarily by targeting c‑Met
- (2018) Wen Wang et al. Oncology Letters
- MicroRNA‑320a suppresses tumour cell proliferation and invasion of renal cancer cells by targeting FoxM1
- (2018) Shiyue Zhao et al. ONCOLOGY REPORTS
- Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells
- (2018) Akihiko Yoshimura et al. BMC CANCER
- MiR-99a-5p inhibits bladder cancer cell proliferation by directly targeting mammalian target of rapamycin and predicts patient survival
- (2018) Yan Liu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- MicroRNA-99a-5p suppresses breast cancer progression and cell-cycle pathway through downregulating CDC25A
- (2018) Hongzhen Qin et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Efforts at maximal cytoreduction improve survival in ovarian cancer patients, even when complete gross resection is not feasible
- (2017) Sumer Wallace et al. GYNECOLOGIC ONCOLOGY
- miR-320a serves as a negative regulator in the progression of gastric cancer by targeting RAB14
- (2017) Yongyuan Li et al. Molecular Medicine Reports
- Human primary liver cancer–derived organoid cultures for disease modeling and drug screening
- (2017) Laura Broutier et al. NATURE MEDICINE
- Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis
- (2016) Annette Becker et al. CANCER CELL
- DNA damage responsive miR-33b-3p promoted lung cancer cells survival and cisplatin resistance by targeting p21WAF1/CIP1
- (2016) Shun Xu et al. CELL CYCLE
- NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer
- (2016) A R Özeş et al. ONCOGENE
- MiR-320a inhibits gastric carcinoma by targeting activity in the FoxM1-P27KIP1 axis
- (2016) Yangyang Wang et al. Oncotarget
- MicroRNA-320a inhibits breast cancer metastasis by targeting metadherin
- (2016) Juan Yu et al. Oncotarget
- Signal Transduction Pathways of EMT Induced by TGF-β, SHH, and WNT and Their Crosstalks
- (2016) Jingyu Zhang et al. Journal of Clinical Medicine
- Epithelial–mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: Prognostic value and prospective role in ovarian cancer therapeutics
- (2014) Maria Koutsaki et al. CANCER LETTERS
- Expression of miR-224-5p is associated with the original cisplatin resistance of ovarian papillary serous carcinoma
- (2014) HENAN ZHAO et al. ONCOLOGY REPORTS
- MicroRNA-320a suppresses in GBM patients and modulates glioma cell functions by targeting IGF-1R
- (2014) Tianzhu Guo et al. TUMOR BIOLOGY
- Enrichment of ovarian cancer stem-like cells is associated with epithelial to mesenchymal transition through an miRNA-activated AKT pathway
- (2013) X. Luo et al. CELL PROLIFERATION
- MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting β-catenin
- (2012) Jian-Yong Sun et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Intracellular clusterin negatively regulates ovarian chemoresistance: compromised expression sensitizes ovarian cancer cells to paclitaxel
- (2011) Mohamed Kamel Hassan et al. TUMOR BIOLOGY
- Designing Early Detection Programs for Ovarian Cancer
- (2009) P. Hartge JNCI-Journal of the National Cancer Institute
- MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN
- (2008) H. Yang et al. CANCER RESEARCH
- MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
- (2008) Douglas D. Taylor et al. GYNECOLOGIC ONCOLOGY
- Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer
- (2008) William M. Merritt et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started